img

Global Human Immune Globulin Intravenous Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Immune Globulin Intravenous Market Insights, Forecast to 2034

Immune globulin (Ig) short-term protection against hepatitis A and measles
Global Human Immune Globulin Intravenous market is expected to reach to US$ 14420 million in 2024, with a positive growth of %, compared with US$ 13360 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Human Immune Globulin Intravenous industry is evaluated to reach US$ 21770 million in 2029. The CAGR will be 7.1% during 2024 to 2029.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Report Covers
This report presents an overview of global Human Immune Globulin Intravenous market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Human Immune Globulin Intravenous market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder

Segment by Application


Immunodeficiency
Autoimmune Disease
Acute Infection

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Human Immune Globulin Intravenous plant distribution, commercial date of Human Immune Globulin Intravenous, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Human Immune Globulin Intravenous introduction, etc. Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Human Immune Globulin Intravenous
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Human Immune Globulin Intravenous Product Introduction
1.2 Market by Type
1.2.1 Global Human Immune Globulin Intravenous Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Market by Application
1.3.1 Global Human Immune Globulin Intravenous Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Immune Globulin Intravenous Sales Estimates and Forecasts 2018-2029
2.2 Global Human Immune Globulin Intravenous Revenue by Region
2.2.1 Global Human Immune Globulin Intravenous Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Human Immune Globulin Intravenous Revenue by Region (2018-2024)
2.2.3 Global Human Immune Globulin Intravenous Revenue by Region (2024-2029)
2.2.4 Global Human Immune Globulin Intravenous Revenue Market Share by Region (2018-2029)
2.3 Global Human Immune Globulin Intravenous Sales Estimates and Forecasts 2018-2029
2.4 Global Human Immune Globulin Intravenous Sales by Region
2.4.1 Global Human Immune Globulin Intravenous Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Human Immune Globulin Intravenous Sales by Region (2018-2024)
2.4.3 Global Human Immune Globulin Intravenous Sales by Region (2024-2029)
2.4.4 Global Human Immune Globulin Intravenous Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Human Immune Globulin Intravenous Sales by Manufacturers
3.1.1 Global Human Immune Globulin Intravenous Sales by Manufacturers (2018-2024)
3.1.2 Global Human Immune Globulin Intravenous Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Immune Globulin Intravenous in 2022
3.2 Global Human Immune Globulin Intravenous Revenue by Manufacturers
3.2.1 Global Human Immune Globulin Intravenous Revenue by Manufacturers (2018-2024)
3.2.2 Global Human Immune Globulin Intravenous Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Immune Globulin Intravenous Revenue in 2022
3.3 Global Key Players of Human Immune Globulin Intravenous, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Human Immune Globulin Intravenous Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Immune Globulin Intravenous, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Immune Globulin Intravenous, Product Offered and Application
3.8 Global Key Manufacturers of Human Immune Globulin Intravenous, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Immune Globulin Intravenous Sales by Type
4.1.1 Global Human Immune Globulin Intravenous Historical Sales by Type (2018-2024)
4.1.2 Global Human Immune Globulin Intravenous Forecasted Sales by Type (2024-2029)
4.1.3 Global Human Immune Globulin Intravenous Sales Market Share by Type (2018-2029)
4.2 Global Human Immune Globulin Intravenous Revenue by Type
4.2.1 Global Human Immune Globulin Intravenous Historical Revenue by Type (2018-2024)
4.2.2 Global Human Immune Globulin Intravenous Forecasted Revenue by Type (2024-2029)
4.2.3 Global Human Immune Globulin Intravenous Revenue Market Share by Type (2018-2029)
4.3 Global Human Immune Globulin Intravenous Price by Type
4.3.1 Global Human Immune Globulin Intravenous Price by Type (2018-2024)
4.3.2 Global Human Immune Globulin Intravenous Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Human Immune Globulin Intravenous Sales by Application
5.1.1 Global Human Immune Globulin Intravenous Historical Sales by Application (2018-2024)
5.1.2 Global Human Immune Globulin Intravenous Forecasted Sales by Application (2024-2029)
5.1.3 Global Human Immune Globulin Intravenous Sales Market Share by Application (2018-2029)
5.2 Global Human Immune Globulin Intravenous Revenue by Application
5.2.1 Global Human Immune Globulin Intravenous Historical Revenue by Application (2018-2024)
5.2.2 Global Human Immune Globulin Intravenous Forecasted Revenue by Application (2024-2029)
5.2.3 Global Human Immune Globulin Intravenous Revenue Market Share by Application (2018-2029)
5.3 Global Human Immune Globulin Intravenous Price by Application
5.3.1 Global Human Immune Globulin Intravenous Price by Application (2018-2024)
5.3.2 Global Human Immune Globulin Intravenous Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Human Immune Globulin Intravenous Market Size by Type
6.1.1 US & Canada Human Immune Globulin Intravenous Sales by Type (2018-2029)
6.1.2 US & Canada Human Immune Globulin Intravenous Revenue by Type (2018-2029)
6.2 US & Canada Human Immune Globulin Intravenous Market Size by Application
6.2.1 US & Canada Human Immune Globulin Intravenous Sales by Application (2018-2029)
6.2.2 US & Canada Human Immune Globulin Intravenous Revenue by Application (2018-2029)
6.3 US & Canada Human Immune Globulin Intravenous Market Size by Country
6.3.1 US & Canada Human Immune Globulin Intravenous Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Human Immune Globulin Intravenous Sales by Country (2018-2029)
6.3.3 US & Canada Human Immune Globulin Intravenous Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Human Immune Globulin Intravenous Market Size by Type
7.1.1 Europe Human Immune Globulin Intravenous Sales by Type (2018-2029)
7.1.2 Europe Human Immune Globulin Intravenous Revenue by Type (2018-2029)
7.2 Europe Human Immune Globulin Intravenous Market Size by Application
7.2.1 Europe Human Immune Globulin Intravenous Sales by Application (2018-2029)
7.2.2 Europe Human Immune Globulin Intravenous Revenue by Application (2018-2029)
7.3 Europe Human Immune Globulin Intravenous Market Size by Country
7.3.1 Europe Human Immune Globulin Intravenous Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Human Immune Globulin Intravenous Sales by Country (2018-2029)
7.3.3 Europe Human Immune Globulin Intravenous Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Human Immune Globulin Intravenous Market Size
8.1.1 China Human Immune Globulin Intravenous Sales (2018-2029)
8.1.2 China Human Immune Globulin Intravenous Revenue (2018-2029)
8.2 China Human Immune Globulin Intravenous Market Size by Application
8.2.1 China Human Immune Globulin Intravenous Sales by Application (2018-2029)
8.2.2 China Human Immune Globulin Intravenous Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Human Immune Globulin Intravenous Market Size by Type
9.1.1 Asia Human Immune Globulin Intravenous Sales by Type (2018-2029)
9.1.2 Asia Human Immune Globulin Intravenous Revenue by Type (2018-2029)
9.2 Asia Human Immune Globulin Intravenous Market Size by Application
9.2.1 Asia Human Immune Globulin Intravenous Sales by Application (2018-2029)
9.2.2 Asia Human Immune Globulin Intravenous Revenue by Application (2018-2029)
9.3 Asia Human Immune Globulin Intravenous Sales by Region
9.3.1 Asia Human Immune Globulin Intravenous Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Human Immune Globulin Intravenous Revenue by Region (2018-2029)
9.3.3 Asia Human Immune Globulin Intravenous Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Immune Globulin Intravenous Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Human Immune Globulin Intravenous Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales by Country
10.3.1 Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Takeda Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Overview
11.2.3 Grifols Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Grifols Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 CSL
11.3.1 CSL Company Information
11.3.2 CSL Overview
11.3.3 CSL Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 CSL Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Octapharma Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Biotest
11.5.1 Biotest Company Information
11.5.2 Biotest Overview
11.5.3 Biotest Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Biotest Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biotest Recent Developments
11.6 Kedrion
11.6.1 Kedrion Company Information
11.6.2 Kedrion Overview
11.6.3 Kedrion Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Kedrion Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kedrion Recent Developments
11.7 Hualan Bio
11.7.1 Hualan Bio Company Information
11.7.2 Hualan Bio Overview
11.7.3 Hualan Bio Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Hualan Bio Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hualan Bio Recent Developments
11.8 CNBG
11.8.1 CNBG Company Information
11.8.2 CNBG Overview
11.8.3 CNBG Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 CNBG Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CNBG Recent Developments
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Company Information
11.9.2 Shanghai RAAS Overview
11.9.3 Shanghai RAAS Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Shanghai RAAS Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shanghai RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Company Information
11.10.2 CBPO Overview
11.10.3 CBPO Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 CBPO Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CBPO Recent Developments
11.11 LFB Group
11.11.1 LFB Group Company Information
11.11.2 LFB Group Overview
11.11.3 LFB Group Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 LFB Group Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 LFB Group Recent Developments
11.12 BPL
11.12.1 BPL Company Information
11.12.2 BPL Overview
11.12.3 BPL Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 BPL Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BPL Recent Developments
11.13 Sichuan Yuanda Shuyang
11.13.1 Sichuan Yuanda Shuyang Company Information
11.13.2 Sichuan Yuanda Shuyang Overview
11.13.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sichuan Yuanda Shuyang Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Immune Globulin Intravenous Industry Chain Analysis
12.2 Human Immune Globulin Intravenous Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Immune Globulin Intravenous Production Mode & Process
12.4 Human Immune Globulin Intravenous Sales and Marketing
12.4.1 Human Immune Globulin Intravenous Sales Channels
12.4.2 Human Immune Globulin Intravenous Distributors
12.5 Human Immune Globulin Intravenous Customers
13 Market Dynamics
13.1 Human Immune Globulin Intravenous Industry Trends
13.2 Human Immune Globulin Intravenous Market Drivers
13.3 Human Immune Globulin Intravenous Market Challenges
13.4 Human Immune Globulin Intravenous Market Restraints
14 Key Findings in The Global Human Immune Globulin Intravenous Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Immune Globulin Intravenous Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of IVIg Liquid
Table 3. Major Manufacturers of IVIg Powder
Table 4. Global Human Immune Globulin Intravenous Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Human Immune Globulin Intravenous Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Human Immune Globulin Intravenous Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Human Immune Globulin Intravenous Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2018-2024)
Table 9. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2024-2029)
Table 10. Global Human Immune Globulin Intravenous Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Human Immune Globulin Intravenous Sales by Region (2018-2024) & (K Units)
Table 12. Global Human Immune Globulin Intravenous Sales by Region (2024-2029) & (K Units)
Table 13. Global Human Immune Globulin Intravenous Sales Market Share by Region (2018-2024)
Table 14. Global Human Immune Globulin Intravenous Sales Market Share by Region (2024-2029)
Table 15. Global Human Immune Globulin Intravenous Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Human Immune Globulin Intravenous Sales Share by Manufacturers (2018-2024)
Table 17. Global Human Immune Globulin Intravenous Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Human Immune Globulin Intravenous, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Human Immune Globulin Intravenous Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Human Immune Globulin Intravenous Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Human Immune Globulin Intravenous by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immune Globulin Intravenous as of 2022)
Table 23. Global Key Manufacturers of Human Immune Globulin Intravenous, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Human Immune Globulin Intravenous, Product Offered and Application
Table 25. Global Key Manufacturers of Human Immune Globulin Intravenous, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Immune Globulin Intravenous Sales by Type (2018-2024) & (K Units)
Table 28. Global Human Immune Globulin Intravenous Sales by Type (2024-2029) & (K Units)
Table 29. Global Human Immune Globulin Intravenous Sales Share by Type (2018-2024)
Table 30. Global Human Immune Globulin Intravenous Sales Share by Type (2024-2029)
Table 31. Global Human Immune Globulin Intravenous Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Human Immune Globulin Intravenous Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Human Immune Globulin Intravenous Revenue Share by Type (2018-2024)
Table 34. Global Human Immune Globulin Intravenous Revenue Share by Type (2024-2029)
Table 35. Human Immune Globulin Intravenous Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Human Immune Globulin Intravenous Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Human Immune Globulin Intravenous Sales by Application (2018-2024) & (K Units)
Table 38. Global Human Immune Globulin Intravenous Sales by Application (2024-2029) & (K Units)
Table 39. Global Human Immune Globulin Intravenous Sales Share by Application (2018-2024)
Table 40. Global Human Immune Globulin Intravenous Sales Share by Application (2024-2029)
Table 41. Global Human Immune Globulin Intravenous Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Human Immune Globulin Intravenous Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Human Immune Globulin Intravenous Revenue Share by Application (2018-2024)
Table 44. Global Human Immune Globulin Intravenous Revenue Share by Application (2024-2029)
Table 45. Human Immune Globulin Intravenous Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Human Immune Globulin Intravenous Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Human Immune Globulin Intravenous Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Human Immune Globulin Intravenous Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Human Immune Globulin Intravenous Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Human Immune Globulin Intravenous Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Human Immune Globulin Intravenous Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Human Immune Globulin Intravenous Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Human Immune Globulin Intravenous Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Human Immune Globulin Intravenous Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Human Immune Globulin Intravenous Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Human Immune Globulin Intravenous Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Human Immune Globulin Intravenous Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Human Immune Globulin Intravenous Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Human Immune Globulin Intravenous Sales by Country (2024-2029) & (K Units)
Table 60. Europe Human Immune Globulin Intravenous Sales by Type (2018-2024) & (K Units)
Table 61. Europe Human Immune Globulin Intravenous Sales by Type (2024-2029) & (K Units)
Table 62. Europe Human Immune Globulin Intravenous Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Human Immune Globulin Intravenous Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Human Immune Globulin Intravenous Sales by Application (2018-2024) & (K Units)
Table 65. Europe Human Immune Globulin Intravenous Sales by Application (2024-2029) & (K Units)
Table 66. Europe Human Immune Globulin Intravenous Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Human Immune Globulin Intravenous Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Human Immune Globulin Intravenous Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Human Immune Globulin Intravenous Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Human Immune Globulin Intravenous Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Human Immune Globulin Intravenous Sales by Country (2018-2024) & (K Units)
Table 72. Europe Human Immune Globulin Intravenous Sales by Country (2024-2029) & (K Units)
Table 73. China Human Immune Globulin Intravenous Sales by Type (2018-2024) & (K Units)
Table 74. China Human Immune Globulin Intravenous Sales by Type (2024-2029) & (K Units)
Table 75. China Human Immune Globulin Intravenous Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Human Immune Globulin Intravenous Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Human Immune Globulin Intravenous Sales by Application (2018-2024) & (K Units)
Table 78. China Human Immune Globulin Intravenous Sales by Application (2024-2029) & (K Units)
Table 79. China Human Immune Globulin Intravenous Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Human Immune Globulin Intravenous Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Human Immune Globulin Intravenous Sales by Type (2018-2024) & (K Units)
Table 82. Asia Human Immune Globulin Intravenous Sales by Type (2024-2029) & (K Units)
Table 83. Asia Human Immune Globulin Intravenous Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Human Immune Globulin Intravenous Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Human Immune Globulin Intravenous Sales by Application (2018-2024) & (K Units)
Table 86. Asia Human Immune Globulin Intravenous Sales by Application (2024-2029) & (K Units)
Table 87. Asia Human Immune Globulin Intravenous Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Human Immune Globulin Intravenous Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Human Immune Globulin Intravenous Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Human Immune Globulin Intravenous Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Human Immune Globulin Intravenous Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Human Immune Globulin Intravenous Sales by Region (2018-2024) & (K Units)
Table 93. Asia Human Immune Globulin Intravenous Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales by Country (2024-2029) & (K Units)
Table 107. Takeda Company Information
Table 108. Takeda Description and Major Businesses
Table 109. Takeda Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Takeda Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Takeda Recent Developments
Table 112. Grifols Company Information
Table 113. Grifols Description and Major Businesses
Table 114. Grifols Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Grifols Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Grifols Recent Developments
Table 117. CSL Company Information
Table 118. CSL Description and Major Businesses
Table 119. CSL Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. CSL Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. CSL Recent Developments
Table 122. Octapharma Company Information
Table 123. Octapharma Description and Major Businesses
Table 124. Octapharma Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Octapharma Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Octapharma Recent Developments
Table 127. Biotest Company Information
Table 128. Biotest Description and Major Businesses
Table 129. Biotest Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Biotest Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Biotest Recent Developments
Table 132. Kedrion Company Information
Table 133. Kedrion Description and Major Businesses
Table 134. Kedrion Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Kedrion Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Kedrion Recent Developments
Table 137. Hualan Bio Company Information
Table 138. Hualan Bio Description and Major Businesses
Table 139. Hualan Bio Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Hualan Bio Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Hualan Bio Recent Developments
Table 142. CNBG Company Information
Table 143. CNBG Description and Major Businesses
Table 144. CNBG Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. CNBG Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. CNBG Recent Developments
Table 147. Shanghai RAAS Company Information
Table 148. Shanghai RAAS Description and Major Businesses
Table 149. Shanghai RAAS Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Shanghai RAAS Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Shanghai RAAS Recent Developments
Table 152. CBPO Company Information
Table 153. CBPO Description and Major Businesses
Table 154. CBPO Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. CBPO Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. CBPO Recent Developments
Table 157. LFB Group Company Information
Table 158. LFB Group Description and Major Businesses
Table 159. LFB Group Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. LFB Group Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. LFB Group Recent Developments
Table 162. BPL Company Information
Table 163. BPL Description and Major Businesses
Table 164. BPL Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. BPL Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. BPL Recent Developments
Table 167. Sichuan Yuanda Shuyang Company Information
Table 168. Sichuan Yuanda Shuyang Description and Major Businesses
Table 169. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Sichuan Yuanda Shuyang Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Human Immune Globulin Intravenous Distributors List
Table 175. Human Immune Globulin Intravenous Customers List
Table 176. Human Immune Globulin Intravenous Market Trends
Table 177. Human Immune Globulin Intravenous Market Drivers
Table 178. Human Immune Globulin Intravenous Market Challenges
Table 179. Human Immune Globulin Intravenous Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Immune Globulin Intravenous Product Picture
Figure 2. Global Human Immune Globulin Intravenous Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Immune Globulin Intravenous Market Share by Type in 2022 & 2029
Figure 4. IVIg Liquid Product Picture
Figure 5. IVIg Powder Product Picture
Figure 6. Global Human Immune Globulin Intravenous Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Human Immune Globulin Intravenous Market Share by Application in 2022 & 2029
Figure 8. Immunodeficiency
Figure 9. Autoimmune Disease
Figure 10. Acute Infection
Figure 11. Human Immune Globulin Intravenous Report Years Considered
Figure 12. Global Human Immune Globulin Intravenous Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Human Immune Globulin Intravenous Revenue 2018-2029 (US$ Million)
Figure 14. Global Human Immune Globulin Intravenous Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2018-2029)
Figure 16. Global Human Immune Globulin Intravenous Sales 2018-2029 ((K Units)
Figure 17. Global Human Immune Globulin Intravenous Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Human Immune Globulin Intravenous Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Human Immune Globulin Intravenous Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Human Immune Globulin Intravenous Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Human Immune Globulin Intravenous Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Human Immune Globulin Intravenous Sales YoY (2018-2029) & (K Units)
Figure 23. China Human Immune Globulin Intravenous Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Human Immune Globulin Intravenous Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Human Immune Globulin Intravenous Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Human Immune Globulin Intravenous Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Human Immune Globulin Intravenous in the World: Market Share by Human Immune Globulin Intravenous Revenue in 2022
Figure 30. Global Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Human Immune Globulin Intravenous Sales Market Share by Type (2018-2029)
Figure 32. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2018-2029)
Figure 33. Global Human Immune Globulin Intravenous Sales Market Share by Application (2018-2029)
Figure 34. Global Human Immune Globulin Intravenous Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Human Immune Globulin Intravenous Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Human Immune Globulin Intravenous Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Human Immune Globulin Intravenous Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Human Immune Globulin Intravenous Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Human Immune Globulin Intravenous Revenue Share by Country (2018-2029)
Figure 40. US & Canada Human Immune Globulin Intravenous Sales Share by Country (2018-2029)
Figure 41. U.S. Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Human Immune Globulin Intravenous Sales Market Share by Type (2018-2029)
Figure 44. Europe Human Immune Globulin Intravenous Revenue Market Share by Type (2018-2029)
Figure 45. Europe Human Immune Globulin Intravenous Sales Market Share by Application (2018-2029)
Figure 46. Europe Human Immune Globulin Intravenous Revenue Market Share by Application (2018-2029)
Figure 47. Europe Human Immune Globulin Intravenous Revenue Share by Country (2018-2029)
Figure 48. Europe Human Immune Globulin Intravenous Sales Share by Country (2018-2029)
Figure 49. Germany Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 50. France Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 51. UK Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 54. China Human Immune Globulin Intravenous Sales Market Share by Type (2018-2029)
Figure 55. China Human Immune Globulin Intravenous Revenue Market Share by Type (2018-2029)
Figure 56. China Human Immune Globulin Intravenous Sales Market Share by Application (2018-2029)
Figure 57. China Human Immune Globulin Intravenous Revenue Market Share by Application (2018-2029)
Figure 58. Asia Human Immune Globulin Intravenous Sales Market Share by Type (2018-2029)
Figure 59. Asia Human Immune Globulin Intravenous Revenue Market Share by Type (2018-2029)
Figure 60. Asia Human Immune Globulin Intravenous Sales Market Share by Application (2018-2029)
Figure 61. Asia Human Immune Globulin Intravenous Revenue Market Share by Application (2018-2029)
Figure 62. Asia Human Immune Globulin Intravenous Revenue Share by Region (2018-2029)
Figure 63. Asia Human Immune Globulin Intravenous Sales Share by Region (2018-2029)
Figure 64. Japan Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 68. India Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Human Immune Globulin Intravenous Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Human Immune Globulin Intravenous Sales Share by Country (2018-2029)
Figure 75. Brazil Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Human Immune Globulin Intravenous Revenue (2018-2029) & (US$ Million)
Figure 80. Human Immune Globulin Intravenous Value Chain
Figure 81. Human Immune Globulin Intravenous Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries